Authors:
Karasawa, M
Tsukamoto, N
Yamane, A
Okamoto, K
Maehara, T
Yokohama, A
Nojima, Y
Omine, M
Citation: M. Karasawa et al., Analysis of the distribution of CAG repeats and X-chromosome inactivation status of HUMARA gene in healthy female subjects using improved fluorescence-based assay, INT J HEMAT, 74(3), 2001, pp. 281-286
Authors:
Yamane, A
Karasawa, M
Maeharal, T
Tsukamoto, N
Nojima, Y
Citation: A. Yamane et al., X chromosome methylation-based chimerism assay for sex-mismatched hematopoietic stem cell transplantation, BONE MAR TR, 28(10), 2001, pp. 969-973
Authors:
Yokohama, A
Karasawa, M
Sakai, H
Okamoto, K
Maehara, T
Tsukamoto, N
Tamura, J
Naruse, T
Sawamura, M
Shimano, S
Citation: A. Yokohama et al., Molecular detection of tumor cells at diagnosis invading the bone marrow and peripheral blood of patients with aggressive or indolent lymphomas, LEUK RES, 25(9), 2001, pp. 749-755
Authors:
Karasawa, M
Masuda, A
Ishibashi, K
Matsumura, H
Citation: M. Karasawa et al., Development of Cat-CVD apparatus - a method to control wafer temperatures under thermal influence of heated catalyzer, THIN SOL FI, 395(1-2), 2001, pp. 71-74
Authors:
Chuman, H
Goto, S
Karasawa, M
Sasaki, M
Nagashima, U
Nishimura, K
Fujita, T
Citation: H. Chuman et al., Three-dimensional structure-activity relationships of synthetic pyrethroids: 2. Three-dimensional and classical QSAR studies, QSAR, 19(5), 2000, pp. 455-466
Authors:
Chuman, H
Goto, S
Karasawa, M
Sasaki, M
Nagashima, U
Nishimura, K
Fujita, T
Citation: H. Chuman et al., Three-dimensional structure-activity relationships of synthetic pyrethroids: 1. Similarity in bioactive conformations and their structure-activity pattern, QSAR, 19(1), 2000, pp. 10-21
Authors:
Saitoh, T
Karasawa, M
Sakuraya, M
Norio, N
Junko, T
Shirakawa, K
Matsushima, T
Tsukamoto, N
Nojima, Y
Murakami, H
Citation: T. Saitoh et al., Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: the serum level of Fas ligand is a marker of LGLleukemia activity, EUR J HAEMA, 65(4), 2000, pp. 272-275
Authors:
Takada, S
Hatsumi, N
Saito, T
Matsushima, T
Sakura, T
Tamura, J
Karasawa, M
Miyawaki, S
Citation: S. Takada et al., Two cases of chronic graft-versus-host disease with elevated levels of soluble Fas ligand in serum, AM J HEMAT, 64(2), 2000, pp. 133-136
Authors:
Murakami, H
Takada, S
Hatsumi, N
Yokohama, A
Saitoh, T
Uchiumi, H
Maehara, T
Matsushima, T
Tsukamoto, N
Morita, K
Tamura, J
Sawamura, M
Karasawa, M
Citation: H. Murakami et al., Multiple myeloma presenting high fever and high serum levels of lactic dehydrogenase, CRP, and interleukin-6, AM J HEMAT, 64(1), 2000, pp. 76-77
Authors:
Yoshida, M
Karasawa, M
Naruse, T
Fukuda, M
Hirashima, K
Oh, H
Ninomiya, H
Abe, T
Saito, K
Shishido, H
Moriyama, Y
Shibata, A
Motoyoshi, K
Nagata, N
Miura, Y
Citation: M. Yoshida et al., Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies, INT J HEMAT, 69(2), 1999, pp. 81-88
Authors:
Murakami, H
Hatsumi, N
Saitoh, T
Mitsui, T
Matsushima, T
Tsukamoto, N
Morita, K
Tamura, J
Karasawa, M
Citation: H. Murakami et al., Electron microscopical analysis of myeloperoxidase of leukemic cells in CD7+stem cell leukemia lymphoma, EUR J HAEMA, 62(5), 1999, pp. 350-351
Authors:
Murakami, H
Kawada, T
Saitoh, T
Uchiumi, H
Moridaira, K
Matsushima, T
Tsukamoto, N
Tamura, J
Morita, K
Sawamura, M
Karasawa, M
Miyawaki, S
Shinonome, S
Shimano, S
Sato, S
Ogawara, H
Tsuchiya, J
Citation: H. Murakami et al., A staging system for multiple myeloma based on the morphology of myeloma cells, EUR J HAEMA, 62(1), 1999, pp. 63-67
Authors:
Yokohama, A
Karasawa, M
Okamoto, K
Sakai, H
Naruse, T
Citation: A. Yokohama et al., ALL- and CML-type BCR ABL mRNA transcripts in chronic myelogenous leukemiaand related disorders, LEUK RES, 23(5), 1999, pp. 477-481
Authors:
Nagata, C
Shimizu, H
Hirashima, K
Kakishita, E
Fujimura, K
Niho, Y
Karasawa, M
Oguma, S
Yoshida, Y
Mizoguchi, H
Citation: C. Nagata et al., Hair dye use and occupational exposure to organic solvents as risk factorsfor myelodysplastic syndrome, LEUK RES, 23(1), 1999, pp. 57-62
Authors:
Kobayashi, S
Sakai, H
Tomiazwa, T
Koiso, H
Kim, K
Ueki, K
Tamura, J
Yano, S
Naruse, T
Karasawa, M
Citation: S. Kobayashi et al., Successful low-dose cytosine arabinoside treatment in a patient with acuteleukemia from idiopathic myelofibrosis, J MED, 30(1-2), 1999, pp. 101-109
Authors:
Karasawa, M
Tsukamoto, N
Sakai, H
Okamoto, K
Maehara, T
Naruse, T
Morita, K
Sato, S
Citation: M. Karasawa et al., Clinical outcome in three patients with myelodysplastic syndrome showing polyclonal hematopoiesis, ACT HAEMAT, 101(1), 1999, pp. 46-49
Authors:
Sato, M
Matsushima, T
Takada, S
Hatsumi, N
Kim, K
Sakuraya, M
Saito, T
Tamura, J
Karasawa, M
Murakami, H
Naruse, T
Citation: M. Sato et al., Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation, BONE MAR TR, 22(12), 1998, pp. 1219-1222